| Serial Number | 97173225 |
| Word Mark | GEN-R |
| Filing Date | Wednesday, December 15, 2021 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, March 25, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, June 27, 2023 |
| Goods and Services | Medical services, namely, medical services utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, namely, therapeutic regulation of immune cells; medical services for treatment of cancer |
| Goods and Services | Scientific and technological services and biological research and development relating thereto, namely, research and development utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, namely, therapeutic regulation of immune cells, in the field of cancer treatment; scientific and technological services and biological research and development, namely, research and development in the field of treatment of cancer |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 20, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 20, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Lyell Immunopharma, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Party Name | Lyell Immunopharma, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | South San Francisco, CA 94080 |
| Event Date | Event Description |
| Monday, March 25, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, March 25, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, August 22, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, June 27, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 27, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, June 7, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, May 25, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, April 21, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, April 20, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 20, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, October 26, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, October 26, 2022 | NON-FINAL ACTION E-MAILED |
| Wednesday, October 26, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, October 20, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, September 21, 2022 | ASSIGNED TO EXAMINER |
| Monday, December 20, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, December 18, 2021 | NEW APPLICATION ENTERED |